In re ACTOS Antitrust Litigation

1:13-cv-09244

Class Action

June 05, 2015
Calif. Ruling Backs Actos Pay-For-Delay Suit, Buyers Say

End-payor plaintiffs accusing Takeda Pharmaceutical Co. and other drugmakers of participating in a pay-for-delay scheme over diabetes drug Actos told a New York federal court Thursday that a recent California Supreme Court ruling in another pay-for-delay case bolsters their argument against the dismissal of their allegations.
May 20, 2015
FTC's Abbvie Loss Doesn't Apply To Actos Case, Court Told

The plaintiffs accusing Takeda Pharmaceutical Co. and other drugmakers of participating in a pay-for-delay scheme for the Actos diabetes drug argued Tuesday in New York federal court that a recent high-profile ruling against the Federal Trade Commission in a similar filing should not have any bearing on the case.
May 13, 2015
Takeda Says FTC's AbbVie Loss Backs Actos Dismissal Bid

Takeda Pharmaceutical Co. Ltd. and several generic-drug makers accused of delaying cheaper versions of diabetes treatment Actos on Tuesday said the recent dismissal of a chunk of one of the Federal Trade Commission's own pay-for-delay cases has doomed the Actos antitrust litigation.